It is broadly accepted that the diagnosis of invasive Candida infections, which are a major cause of sepsis, should be based on simultaneous determination of multiple biomarkers including early inflammatory markers (CRP, PCT, and PSEP) and at least one highly specific biomarker, such as the panfungal antigen BDG [4,30,31]. This evidence concerns the gene CRP and Sepsis.